Cargando…
Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway
Multiple sclerosis (MS), a T-cell-mediated autoimmune disease that affects the central nervous system (CNS), is characterized by white matter demyelination, axon destruction, and oligodendrocyte degeneration. Ivermectin, an anti-parasitic drug, has anti-inflammatory, anti-tumor, and antiviral proper...
Autores principales: | Xie, Yu, Jin, Chaolei, Sang, Hongzhen, Liu, Wenhua, Wang, Junpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209955/ https://www.ncbi.nlm.nih.gov/pubmed/37227550 http://dx.doi.org/10.1007/s10753-023-01829-y |
Ejemplares similares
-
Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance
por: Zhou, Yan, et al.
Publicado: (2016) -
The Balance of Th17 versus Treg Cells in Autoimmunity
por: Lee, Gap Ryol
Publicado: (2018) -
Therapeutic Effect of Ginsenoside Rd on Experimental Autoimmune Encephalomyelitis Model Mice: Regulation of Inflammation and Treg/Th17 Cell Balance
por: Jin, Bo, et al.
Publicado: (2020) -
Rotating magnetic field ameliorates experimental autoimmune encephalomyelitis by promoting T cell peripheral accumulation and regulating the balance of Treg and Th1/Th17
por: Zhan, Tianying, et al.
Publicado: (2020) -
MiR-384 Regulates the Th17/Treg Ratio during Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Qu, Xuebin, et al.
Publicado: (2017)